L. Oomen

Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors

Kenneth C. Anderson, Paul W. H. I. Parren, Jerry W. Slootstra, 2011, The Journal of Immunology.

Are the Enzyme Immunoassays for Antibodies to Pneumococcal Capsular Polysaccharides Serotype Specific?

H. Käyhty, L. Oomen, A. Soininen, 2000, Clinical Diagnostic Laboratory Immunology.

Immunogenicity of Streptococcus pneumoniae type 6B and 14 polysaccharide-tetanus toxoid conjugates and the effect of uncoupled polysaccharide on the antigen-specific immune response.

L. van Buren, J. Poolman, P. Hoogerhout, 1998, Vaccine.

Preparation of polysaccharide-conjugate vaccines.

J. Poolman, P. Hoogerhout, L. Oomen, 2003, Methods in molecular medicine.

Preparation of monoclonal mouse antibodies against two specific eu-melanin related compounds.

L. Oomen, A. Kammeyer, S. Pavel, 1992, Journal of immunological methods.

Daratumumab, a Novel Potent Human Anti-CD38 Monoclonal Antibody, Induces Significant Killing of Human Multiple Myeloma Cells: Therapeutic Implication.

P. Parren, N. Munshi, P. Richardson, 2009 .